- Home
- VRCA vs ICMB Comparison
VRCA vs ICMB Comparison
Compare VRCA & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- ICMB
- Stock Information
- Founded
- VRCA 2013
- ICMB 2012
- Country
- VRCA United States
- ICMB United States
- Employees
- VRCA N/A
- ICMB N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- VRCA Health Care
- ICMB Finance
- Exchange
- VRCA Nasdaq
- ICMB Nasdaq
- Market Cap
- VRCA 43.0M
- ICMB 41.1M
- IPO Year
- VRCA 2018
- ICMB N/A
- Fundamental
- Price
- VRCA $0.54
- ICMB $2.75
- Analyst Decision
- VRCA Hold
- ICMB
- Analyst Count
- VRCA 5
- ICMB 0
- Target Price
- VRCA $6.00
- ICMB N/A
- AVG Volume (30 Days)
- VRCA 263.8K
- ICMB 45.7K
- Earning Date
- VRCA 05-13-2025
- ICMB 05-13-2025
- Dividend Yield
- VRCA N/A
- ICMB 17.81%
- EPS Growth
- VRCA N/A
- ICMB N/A
- EPS
- VRCA N/A
- ICMB 0.82
- Revenue
- VRCA $7,179,000.00
- ICMB $20,996,189.00
- Revenue This Year
- VRCA $127.85
- ICMB N/A
- Revenue Next Year
- VRCA $105.09
- ICMB N/A
- P/E Ratio
- VRCA N/A
- ICMB $3.27
- Revenue Growth
- VRCA N/A
- ICMB N/A
- 52 Week Low
- VRCA $0.38
- ICMB $2.46
- 52 Week High
- VRCA $9.36
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- VRCA 43.40
- ICMB 39.62
- Support Level
- VRCA $0.49
- ICMB $2.76
- Resistance Level
- VRCA $0.73
- ICMB $2.82
- Average True Range (ATR)
- VRCA 0.07
- ICMB 0.12
- MACD
- VRCA -0.01
- ICMB -0.02
- Stochastic Oscillator
- VRCA 10.77
- ICMB 11.27
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.